| Arash Taleghani, MD | |
|
Dept Of Anesthesiology, National Naval Medical Center, 8901 Wisconsin Ave., Bethesda, MD 20889 | |
| (301) 295-4455 | |
| Not Available |
| Full Name | Arash Taleghani |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 22 Years |
| Location | Dept Of Anesthesiology, National Naval Medical Center, Bethesda, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083786313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | A85241 (California) | Primary |
| 207L00000X | Anesthesiology | D0065648 (Maryland) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Montgomery Medical Center | Olney, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
News Archive
AtCor Medical the developer and marketer of the SphygmoCor® system which measures central blood pressure and arterial stiffness noninvasively, today announced the publication of a key National Institutes of Health (NIH)-funded study(1) using SphygmoCor in the Journal of the American College of Cardiology (JACC).
Helix BioPharma Corp. today announced progress updates for its ongoing Topical Interferon Alpha-2b and L-DOS47 product development programs following pre-investigational new drug ("pre-IND") meetings with the U.S. Food and Drug Administration ("FDA").
As many as one in ten elderly people in the US, registered with Medicare, do not stick to their prescribed medication because it is too expensive, according to Dr. Larissa Nekhlyudov and colleagues from Harvard Medical School.
New public opinion surveys released today by the nonprofit Alliance for Aging Research show that public awareness about heart valve disease (HVD) in the U.S. is alarmingly low.
Depression, known to be a condition with impaired psychosocial functioning that severely impacts the quality of life of patients and families, is actually defined with specific clinical symptoms such as sadness, difficulty to experience pleasure, sleep problems etc., present for at least two weeks. At least 40% of depressed patients actually benefit from an antidepressant treatment, whereas 20-30% of patients may suffer from chronic depression that negatively impacts their quality of life. In order to improve the efficiency of treatment and reduce the burden of depressive disorders, depression needs to be defined at the neurobiological level.
› Verified 4 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171129001837 |
News Archive
AtCor Medical the developer and marketer of the SphygmoCor® system which measures central blood pressure and arterial stiffness noninvasively, today announced the publication of a key National Institutes of Health (NIH)-funded study(1) using SphygmoCor in the Journal of the American College of Cardiology (JACC).
Helix BioPharma Corp. today announced progress updates for its ongoing Topical Interferon Alpha-2b and L-DOS47 product development programs following pre-investigational new drug ("pre-IND") meetings with the U.S. Food and Drug Administration ("FDA").
As many as one in ten elderly people in the US, registered with Medicare, do not stick to their prescribed medication because it is too expensive, according to Dr. Larissa Nekhlyudov and colleagues from Harvard Medical School.
New public opinion surveys released today by the nonprofit Alliance for Aging Research show that public awareness about heart valve disease (HVD) in the U.S. is alarmingly low.
Depression, known to be a condition with impaired psychosocial functioning that severely impacts the quality of life of patients and families, is actually defined with specific clinical symptoms such as sadness, difficulty to experience pleasure, sleep problems etc., present for at least two weeks. At least 40% of depressed patients actually benefit from an antidepressant treatment, whereas 20-30% of patients may suffer from chronic depression that negatively impacts their quality of life. In order to improve the efficiency of treatment and reduce the burden of depressive disorders, depression needs to be defined at the neurobiological level.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arash Taleghani, MD 1527 Templeton Pl, Rockville, MD 20852-1441 Ph: () - | Arash Taleghani, MD Dept Of Anesthesiology, National Naval Medical Center, 8901 Wisconsin Ave., Bethesda, MD 20889 Ph: (301) 295-4455 |
News Archive
AtCor Medical the developer and marketer of the SphygmoCor® system which measures central blood pressure and arterial stiffness noninvasively, today announced the publication of a key National Institutes of Health (NIH)-funded study(1) using SphygmoCor in the Journal of the American College of Cardiology (JACC).
Helix BioPharma Corp. today announced progress updates for its ongoing Topical Interferon Alpha-2b and L-DOS47 product development programs following pre-investigational new drug ("pre-IND") meetings with the U.S. Food and Drug Administration ("FDA").
As many as one in ten elderly people in the US, registered with Medicare, do not stick to their prescribed medication because it is too expensive, according to Dr. Larissa Nekhlyudov and colleagues from Harvard Medical School.
New public opinion surveys released today by the nonprofit Alliance for Aging Research show that public awareness about heart valve disease (HVD) in the U.S. is alarmingly low.
Depression, known to be a condition with impaired psychosocial functioning that severely impacts the quality of life of patients and families, is actually defined with specific clinical symptoms such as sadness, difficulty to experience pleasure, sleep problems etc., present for at least two weeks. At least 40% of depressed patients actually benefit from an antidepressant treatment, whereas 20-30% of patients may suffer from chronic depression that negatively impacts their quality of life. In order to improve the efficiency of treatment and reduce the burden of depressive disorders, depression needs to be defined at the neurobiological level.
› Verified 4 days ago
Dr. Bradley Allen Ullman, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 8901 Rockville Pike, Bethesda, MD 20889 Phone: 740-336-9469 | |
Quentin A Fisher, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 6213 Stoneham Rd, Bethesda, MD 20817 Phone: 301-530-0125 | |
Dr. Mark E Schutz, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 5110 Ridgefield Rd, Bethesda, MD 20816 Phone: 301-652-7130 | |
Dr. Rupa J. Dainer, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 8901 Wisconsin Avenue, Bethesda, MD 20889 Phone: 301-295-4455 | |
Dr. Eric J Miano, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: National Naval Medical Ctr, 8901 Wisconsin Avenue, Bethesda, MD 20889 Phone: 301-295-4455 | |
David Eric Lees, M.D Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5864 Marbury Rd, Bethesda, MD 20817 Phone: 301-229-6755 Fax: 301-229-6755 | |
Karim Lashin, D.O Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8600 Old Georgetown Rd, Bethesda, MD 20814 Phone: 301-896-3100 |